The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 28, Issue 3-4, 1998, Pages 231-239

  Deliliers, Giorgio Lambertenghi ^a   Annaloro, Claudio ^a   Soligo, Davide ^a   Oriani, Alessandro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone marrow biopsy; Immunohistochemistry; Monoclonal antibodies; Myelodysplastic syndromes

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY;

BONE MARROW BIOPSY; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; DIAGNOSTIC ACCURACY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0031929506     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809092679     Document Type: Review

References (46)

1. Kitagawa, M., Kamiyama, R., Takemura, T. and Kasuga, T. (1989). Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Arch. B: Cell. Pathol., 57, 47-53.
2. Sultan, C., Sigaux, F., Imbert, M. and Reyes, F. (1981). Acute myelodysplasia with myelofibrosis: a report of eight cases. Br. J. Haematol., 49, 11-16.
3. Pagliuca, A., Layton, D. M., Manoharan, A., Gordon, S., Green, P. J. and Mufti, GJ. (1989). Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of ten cases. Br. J. Haematol., 71, 499-504.
4. Lambertenghi Deliliers, G., Orazi, A., Luksch, R., Annaloro, C. and Soligo, D. (1991). Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br. J. Haematol., 78, 161-166.
5. Tricot, G., De Wolf-Peeters, C., Vlientinck, R. and Verwilghen, R. L. (1984). Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br. J. Haematol., 58, 217-225.
6. Lambertenghi-Deliliers, G., Annaloro, C., Oriani, A., Soligo, D., Pozzoli, E. and Polli, E. E. (1993). Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Annals of Hematol, 66, 85-91.
7. Kitagawa, M., Kamiyama, R. and Kasuga, T. (1993). Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum. Pathol., 24, 359-363.
8. Verhoef, G. E. G., De Wolf-Peeters, C., Ferrant, A., Deprez, S., Meeus, P., Stul, M., Zacheé, P., Cassiman, J. J., Van den Berghe, H. and Boogaerts. M. A. (1991). Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann. Hematol., 63, 235-241.
9. Cordell, J. L., Falini, B., Erber, W. N., Ghoshak, A. K., Zainalabidden, A., MacDonald, S., Pulford, K. A. F., Stein, H. and Mason, D. Y. (1984). Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem. Cytochem., 32, 219-229.
10. Mangi, M. H. and Mufti, G. J. (1992). Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood, 79, 198-205.
11. Elghetany, M. T., Sullivan, A. K., Kurec, A. S., MacCallum, J. M., Bloomfield, C. D., Sobol, R. E. and Davey, F. R. (1992). The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells. Am. J. Clin. Pathol., 98, 430-436.
12. Orazi, A., Cattoretti, G., Soligo, D., Luksch, R. and Lambertenghi Deliliers, G. (1993). Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. Leukemia, 7, 838-847.
13. Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezzella, F., Pierotti, M. A. and Della Porta, G. (1992). bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood, 79, 1291-1298.
14. Titius, B. R., Thiele, J., Schaefer, H., Kreipe, H. and Fischer, R. (1994). Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Immunohistochemical and morphometric study including reactive (inflammatory) myelitis, secondary aplastic anemia, AIDS, myelodysplastic syndromes and primary (idiopathic) osteomyelofibrosis. Acta Haematol., 91, 144-149.
15. Werner, M., Kaloutsi, V., Walter, K., Buhr, T., Bernhards, J. and Georgii, A. (1992). Immunohistochemical examination of routinely processed bone marrow biopsies. Pathol. Res. Pract., 188, 707-713.
16. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood, 86, 1464-1468.
17. Guyotat, D., Campos, L., Thomas, X., Vila, L., Shi, Z., Charrin, C., Gentilhomme, O. and Fiere, D. (1990). Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns. Am. J. Hematol., 34, 26-31.
18. Seo, I. S., Li, C. Y. and Yam, L. T. (1993). Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies. Mayo Clin. Proc., 68, 47-53.
19. Felzmann, T., Gisslinger, H. and Ludwig, H. (1994). Immunologic findings in patients with myelodysplastic syndrome. Leukemia and Lymphoma, 15, 201-208.
20. Keim, D. R. and Hanash. S. M. (1992). Proliferating cell nuclear antigen; a new marker of proliferation in cancer. Leukemia and Lymphoma, 6, 459-468.
21. Thiele, J., Quitmann, H., Wagner, S. and Fischer, R. (1991). Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. J. Clin. Pathol., 44, 300-305.
22. Thiele, J., Titius, B. R., Kopsidis, C. and Fischer, R. (1992). Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Virchows Arch. B: Cell. Pathol. Incl. Mol. Pathol., 62, 275-282.
23. Thiele, J., Titius, B. R., Quitmann, H., Fischer, R., Salzberger, B., Dienemann, D. and Stein, H. (1992). Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells. Pathol. Res. Pract., 188, 722-728.
24. Thiele, J., Hoffmann, I., Bertsch, H. P. and Fischer, R. (1993). Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes. Virchows Arch. A: Pathol. Anat. Histopathol., 423, 33-38.
25. Maschek, H., Georgii, A., Kaloutsi, V., Werner, M., Bandecar, K., Kressel, M. G., Choritz, H., Freund, M. and Hufnagl, D. (1992). Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur. J. Haematol., 48, 208-214.
26. Hockenbery, D. M., Zutter, M., Mickey, W., Nahm, M. and Korsmeyer, S. J. (1991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A., 88, 6961-6965.
27. Eastman, A. (1990). Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280.
28. Lepelley, P., Preudhomme, C., Vanrumbeke, M., Quesnel, B., Cosson, A. and Fenaux, P. (1994). Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia, 8, 1342-1349.
29. Kitagawa, M., Yoshida, S., Kuwata, T., Tanizawa, T. and Kamiyama, R. (1994). p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am. J. Pathol., 145, 338-344.
30. Orazi, A., Cattoretti, G., Heerema, N. A., Sozzi, G., John, K. and Neiman, R. S. (1993). Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Mod. Pathol., 6, 521-525.
31. Zhou, D., Marie, J. P., Suberville, A. M. and Zittoun, R. (1992). Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia, 6, 879-885.
32. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. and Fiere, D. (1992). Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473-176.
33. + acute myeloid leukemia cells. Blood, 82, 3157-3162.
34. Lepelley, P., Soenen, V., Preudhomme, C., Lai, J. L., Cosson, A. and Fenaux, P. (1994). Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes. Leukemia, 8, 998-1004.
35. McCormick, D. and Hall, P. (1992). The complexities of proliferating cell nuclear antigen. Histopathology, 21, 591-594.
36. + in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia, 5, 1026-1030.
37. Borowitz, M. J., Gockerman, J. P., Moore, J. O., Civin, C., Page, S. O., Robertson, J. and Bigner, S. H. (1989). Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol., 91, 265-270.
38. Geller, R. B., Zahurak, M., Hurwitz, C. A., Burke, P. J., Karp, J. E., Piantadosi, S. and Civin, C. I. (1990). Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of stem-cell glycoprotein CD34 (MY 10). Br. J. Haematol., 76, 340-347.
39. Campos, L., Guyotat, D., Archimbaud, E., Devaux, Y., Treille, D., Larese, A., Maupas, J., Gentilhomme, O., Ehrsam, A. and Fiere, D. (1989). Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol., 72, 161-166.
40. Sperling, C., Büchner, T., Creutzig, U., Ritter, J., Harbott, J., Fonatsch, C., Sauerland, C., Mielcarek, M., Maschmeyer, G., Löffler, H. and Wolf-Dieter, L. (1995). Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leukemia and Lymphoma, 17, 417-426.
41. + cells: an adverse prognostic factor in the myelodysplastic syndromes. Am. J. Hematol., 39, 96-101.
42. Oertel, J., Oertel, B., Beyer, J. and Huhn, D. (1994). CD34 immunotyping of blasts in myelodysplasia. Ann. Hematol., 68, 77-80.
43. + cells. Leukemia and Lymphoma, 14, 37-47.
44. + cells. Blood, 85, 194-202.
45. Soligo, D. A., Oriani, A., Annaloro, C., Cortelezzi, A., Calori, R., Pozzoli, E., Nosella, D., Orazi, A. and Lambertenghi Deliliers, G. (1994). CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Am. J. Hematol., 46, 9-17.
46. Oriani, A., Annaloro, C., Soligo, D., Pozzoli, E., Cortelezzi, A. and Lambertenghi Deliliers, G. (1996). Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes. Br. J. Haematol., 92, 360-354.